Search Results 91-100 of 3418 for Solid

  1. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

    A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors · Overview · Participation eligibility · Participating Mayo Clinic locations.

  2. PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona - Curriculum

    Curriculum. Two residents in the Solid Organ Transplant Residency at Mayo Clinic in Arizona look at a. Clinical training.

  3. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    About this study. The purpose of the trial is to establish the tolerability of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors.

  4. Mayo Clinic Q&A podcast: 2020 was a record year for solid organ transplants, even amid COVID-19 pandemic

    Despite the COVID-19 pandemic the center performed the most solid organ transplants across its three campuses in Arizona, Florida and Minnesota, than any time ...

  5. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

    ... solid tumors in phase 1. Primary objective of Phase 1b is to assess overall response rate (ORR) determined by Investigator per RECIST v1.1 for patients in ...

  6. A Study of MT-5111 in HER2-positive Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate dose escalation and expansion of MT-5111 (a recombinant fusion protein) in subjects with HER2-positive solid tumors.

  7. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

    Clinical Trials · Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study.

  8. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration - Mayo Clinic

    Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration · Overview · Participation eligibility · Participating Mayo Clinic ...

  9. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

    This Phase 1/2 study will enroll patients with various advanced solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and ...

  10. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

    Patients in the study will be treated with Melphalan/HDS and will receive up to 6 total treatments. This study will evaluate the safety and effects of the ...